Mjn-neuro’s wearable earpiece sensor continuously records the brain activity of epilepsy patients. Using artificial intelligence (AI), Episera analyses electrical brain patterns to determine when a seizure is likely to occur. Pairing with a dedicated smartphone app, the sensor sends an alert minutes before a seizure is forecast to occur when it interprets that risk levels are high.

Episera, which is intended for homecare and ambulatory use, is the first digital health tool for real-time early seizure detection, according to the companies. The device is classified as a Class IIa medical device and gained a European CE mark in 2020. Episera’s European commercialisation will be handled by German pharma Neuraxpharma.